PCOS in the News
Latest Research & Coverage
33 curated articles from leading medical journals, clinical publications, and news outlets — covering breakthroughs, treatment advances, and evolving understanding of PCOS.
Showing all 33 articles
PCOS impacts 6 million U.S. women, but doctors still misdiagnose the symptoms
Despite affecting millions of reproductive-age women, PCOS remains routinely misdiagnosed — with patients often waiting years and visiting multiple providers before receiving a correct diagnosis.
Mount Sinai–Duke University study identifies DNA variants that increase testosterone production in PCOS patients
Researchers for the first time demonstrated that inherited DENND1A gene variants directly increase testosterone production in a human PCOS cell model, providing a clear mechanistic link between genetics and the hormonal features of PCOS.
Weight loss drugs could help treat PCOS
GLP-1 prescriptions among women with PCOS have surged sevenfold since 2021. Patients and physicians report menstrual cycle improvements, weight loss, and reduced symptoms — though these drugs are not FDA-approved for PCOS.
ENDO 2025: Advances in PCOS, obesity, diabetes, and endocrine disorder research
A roundup of the most significant PCOS findings from the 2025 Endocrine Society annual meeting, covering new subtypes, GLP-1 data, metabolic risk stratification, and emerging therapeutic targets.
Researchers identify 4 distinct PCOS subtypes to guide treatment
Analysis of nearly 12,000 women across five international cohorts identified four reproducible PCOS subtypes — hyperandrogenic, obesity-dominant, high-SHBG, and elevated LH/AMH — each with distinct fertility outcomes and treatment response profiles.
PCOS and Mental Health: Symptoms, Coping, and Treatment
UPMC clinicians explain how PCOS drives anxiety and depression through hormonal, metabolic, and psychosocial pathways — and outline treatment options including CBT, medication, and lifestyle modification.
Epigenetic clues in PCOS embryos reveal new pathways for diagnosis
Scientists have identified a distinctive 'epigenetic memory' in embryos from women with PCOS, potentially explaining the condition's hereditary transmission and opening avenues for earlier, molecular-level diagnosis.
First-trimester metformin use linked to improved pregnancy outcomes in PCOS patients
Continuing metformin into the first trimester was associated with higher clinical pregnancy and live birth rates in women with PCOS undergoing fertility treatment, offering new data to guide clinical decision-making.
PCOS with diagnosed depression may signal greater cardiometabolic risk
Women with PCOS who also have a depression diagnosis are 56% more likely to develop metabolic syndrome, significantly elevating their risk for type 2 diabetes and cardiovascular disease.
Lean PCOS linked to adipose tissue dysfunction in adolescents
New research shows that even normal-weight adolescents with PCOS exhibit meaningful adipose tissue dysfunction and insulin resistance, challenging assumptions that PCOS metabolic risks are tied solely to obesity.
GLP-1 receptor agonists may alleviate symptoms in patients with PCOS
Clinical review of emerging evidence that GLP-1 medications like semaglutide and tirzepatide may improve menstrual regularity, reduce hyperandrogenism, and address the insulin resistance at the core of PCOS — particularly for patients with comorbid obesity.
Looking in all directions: Exploring a new horizon for PCOS therapeutics
Vanderbilt researchers map an emerging landscape of PCOS treatment targets — from androgen pathway modulators to GLP-1 agonists and gut microbiome interventions — as the field moves toward precision approaches.
PCOS patients report feeling dismissed by health care providers
Survey data reveals that many women with PCOS experienced provider dismissal of their symptoms, with 33% having received a prior misdiagnosis — disproportionately affecting Black women and those with lower-income insurance coverage.
PCOS and diabetes: understanding the metabolic link
A clinical deep-dive into the shared insulin resistance pathway connecting PCOS and type 2 diabetes, plus updated guidance on glucose screening intervals and early pharmacological prevention.
New research could change how we treat PCOS
Scientists are rethinking PCOS as a broader metabolic-reproductive disorder detectable from childhood, opening the door to earlier intervention and entirely new treatment strategies.
Study reveals critical gaps in care for PCOS patients
Presented at the 2024 ACOG Annual Meeting, the study found that PCOS — affecting approximately 10% of females — is frequently underdiagnosed, undertreated, and underresearched, with time to diagnosis ranging from 2 months to 13 years.
Antimalarial drug demonstrates promising results in easing PCOS symptoms
Dihydroartemisinin pilot trial results show testosterone normalization, fewer polycystic follicles, and restored menstrual regularity — raising hopes for a repurposed drug class with an established safety record.
Anti-malarial compound shows promise for treating polycystic ovary syndrome
Precision medicine coverage of the artemisinin breakthrough, including the drug's preclinical and pilot human trial results showing reduced ovarian cysts, lower AMH levels, and improved hormonal profiles.
Antimalarial drugs could also treat polycystic ovary syndrome
The American Chemical Society covers the artemisinin PCOS discovery, explaining how the drug's novel mitochondrial mechanism — degrading CYP11A1 — offers a fundamentally different approach to reducing androgen overproduction.
A malaria drug could be used to treat PCOS, a common hormone disorder
A landmark study published in Science found that artemisinin-class antimalarial drugs sharply reduced testosterone in PCOS patients, restored normal menstrual cycles in over half of trial participants, and showed no significant side effects.
PCOS: Why symptoms matter more than a 'label'
Yale Medicine physicians challenge the 'one-size-fits-all' view of PCOS, arguing that symptom-based, individualized care is more effective than relying solely on a diagnostic label that can both over- and under-identify the condition.
PCOS symptoms are still difficult for doctors to diagnose and treat. Here's why.
Despite being identified 90 years ago, PCOS still has no FDA-approved drugs specifically for it, and its wide symptom variation makes diagnosis a prolonged, frustrating journey for many women.
The connection between PCOS and heart health
UCLA cardiologists explain how PCOS increases cardiovascular risk through insulin resistance, chronic inflammation, and dyslipidemia — and what women with PCOS can do to protect heart health starting in their 20s.
PCOS linked with cognitive decline at midlife
Harvard's clinical commentary on the landmark Neurology study connects PCOS's metabolic burden to neurological risk, urging clinicians to consider cognitive screening in long-term PCOS management.
New study finds a link between PCOS and cognitive decline
Healthcare advisory perspective on the PCOS-cognitive decline findings, highlighting implications for clinical monitoring protocols and the need for PCOS to be treated as a lifelong metabolic condition.
Could PCOS lead to memory, thinking problems later in life?
Following the Neurology publication, Medical News Today breaks down what the PCOS-cognitive decline link means for patients and what the proposed biological mechanisms — including insulin resistance and chronic inflammation — may be.
PCOS linked to cognitive decline in midlife
Neuroscience-focused coverage examining how PCOS-related hyperandrogenism and metabolic dysfunction may accelerate brain aging, with practical implications for both patients and providers.
People with polycystic ovary syndrome may have memory and thinking problems in midlife
Detailed coverage of the PCOS brain health study noting that women with PCOS scored worse on three of five cognitive tests and showed subtle MRI changes that may indicate early neural aging.
PCOS linked with cognitive decline, study finds
A 30-year longitudinal study found that women with PCOS scored around 11% lower on memory, attention, and verbal tests at midlife, and showed early signs of brain aging on MRI — adding cognitive health to PCOS's long-term risk profile.
PCOS tied to memory, thinking problems
ScienceDaily's coverage of the 30-year CARDIA cohort study, which found reduced white matter integrity on brain scans and lower cognitive test scores in women with PCOS compared to those without the condition.
Diabetes and Polycystic Ovary Syndrome (PCOS)
The CDC's resource outlining why women with PCOS are at significantly elevated risk for type 2 diabetes and prediabetes, with guidance on screening and preventive measures.
2023 International Evidence-Based Guideline for the Assessment and Management of PCOS — ASRM Practice Guidance
ASRM's clinical practice summary of the 2023 international PCOS guidelines — covering updated fertility treatment algorithms, lifestyle intervention requirements, emotional wellbeing assessment, and the new AMH diagnostic pathway.
New international practice guidelines released for polycystic ovary syndrome
The 2023 International Evidence-Based PCOS Guidelines, developed by 39 organizations across 71 countries, update diagnostic criteria, expand mental health screening mandates, and add AMH as an alternative diagnostic tool.
Articles link to their original sources. PCOS Doctors curates reputable coverage for informational purposes only — nothing here constitutes medical advice. Privacy · Terms
Find a PCOS Doctor →